default_top_notch
default_news_top
default_news_ad1
default_nd_ad1

AstraZeneca Korea elects Kim Sang-pyo as new CEO

Marian Chu  Published 2018.02.05  14:47  Updated 2018.02.05 15:03

공유
default_news_ad2

AstraZeneca Korea said Kim Sang-pyo took office as its new CEO on Monday. Kim had led MSD Korea’s oncology department from 2016 after acquiring more than 10 years of experience in the industry.

AstraZeneca Korea's new CEO Kim Sang-pyo

The Korean branch of AstraZeneca expressed high expectations for Kim, saying that his experience in the field of oncology will help expand the company’s anticancer portfolio.

“Kim’s various experiences and insights will lead AstraZeneca to reach new heights as the company is currently expanding its anticancer drug portfolio,” the company said in a statement.

yjc@docdocdoc.co.kr

<© KBR , All rights reserved.>
default_news_ad5
default_news_bottom
default_nd_ad4
default_bottom
#top
default_bottom_notch